FDA Approval of Astepro

Released: 08/05/2021  

The FDA recently approved the nasal antihistamine, Astepro (azelastine hydrochloride nasal spray, 0.15%), for nonprescription use through a process called a partial prescription to nonprescription switch. Astepro is FDA approved to treat seasonal and perennial allergic rhinitis -commonly known as allergies- for adults and children six years and older.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com.

The post FDA Approval of Astepro appeared first on Carlisle Medical.